Course Information

9th Annual UCLA Review of Clinical Neurology

A Virtual Course

March 24, 2023 to March 26, 2023

*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Syllabus for Conference Registrants

Download: [ PDF ]

The UCLA Review of Clinical Neurology Virtual CME Course is designed to provide a comprehensive and practical review of core neurological disorders. It is intended for neurologists who wish to strengthen their competency and proficiency in evaluating, diagnosing, and managing a broad range of neurological disorders.

The course is organized to provide attendees with a review of clinical neurology based on major disease topics. Each neurological core topic will be organized to summarize the clinical spectrum of the disorders, pathophysiology, etiology, diagnostic techniques, and management options. Each lecture will discuss recent advancements made in the last year and their relevance to COVID-19.

Target Audience

This course is designed for practicing neurologists in private, health groups, or academic practice, as well as neurology, psychiatry, and neurosurgery trainees (residents, fellows). The course will also be very helpful for allied healthcare providers in neuroscience specialties (psychologists, physician assistants, nurses, and nurse practitioners, speech pathologists, and physical and occupational therapists.

General Information

Virtual meeting instructions in anticipation of the course will be provided to enrollees two weeks prior to the conference date.

Enrollees will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.

Course Fees

Register by March 1, 2023 to take advantage of pre-registration rates.

$650 Physicians (pre-registration)

$750 Physicians (after March 1, 2023)

$350 Allied Health Professionals (pre-registration)

$500 Allied Health Professionals (after March 1, 2023)

$300 Trainees

Enroll Online

We accept Visa, MasterCard, American Express, Discover credit cards, and ACH/electronic payment.

To register using a credit card or ACH/electronic transfer, click here.

*Credit card and check payments via phone, fax, or mail are no longer accepted.


Cancellations must be received March 13, 2023 by email to and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.


If you have questions about enrollment, please call (310) 794-2620 or email

Course Directors

Alon Y. Avidan MD, MPH
Professor of Neuorology
UCLA Department of Neurology*

Kevin R. Patel, MD
Assistant Clinic Professor
Multiple Sclerosis Program
UCLA Department of Neurology*


Course Faculty


Ayush Batra, MD
Assistant Professor
Division of Stroke and Neurocritical Care
Department of Neurology & Pathology
Northwestern University Feinberg School of Medicine
Chicago, IL

Shamik Bhattacharyya, MD
Assistant Professor of Neurology Harvard Medical School
Department of Neurology, Brigham and Woman’s Hospital
Boston, MA

Anna D. Burke, MD
Karsten Solheim Chair for Dementia
Director of the Alzheimer’s and Memory Disorders Division
Director of Neuropsychiatry
Department of Neurology
Barrow Neurological Institute
Phoenix, AZ

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
UCLA Department of Neurology*

Robert A. Chong, MD, PhD
Assistant Professor
UCLA Department of Neurology*

Jonathan C. Edwards, MD
Chair of Neurology
Medical University of South Carolina
Charleston, SC

Brent L. Fogel, MD, PhD
Professor of Neurology and Human Genetics
Director, Neurogenetics Clinic & Clinical Neurogenomics Research Center
UCLA Department of Neurology*

Barbara Giesser, MD
Professor Emeritus of Clinical Neurology
Staff Psysician, Pacific Neuroscience Institute
Santa Monica, CA

Langston Holly, MD
Professor of Neurosurgery and Orthopaedics
Vice Chair of Clinical Affairs and Executive Vice Chair
Ulrich Batzdorf Endowed Chair in Spinal Neurosurgery
Department of Neurosurgery*

Gail Ishiyama, MD
Professor of Neurology
UCLA Department of Neurology*

Adrienne M Keener, MD
Associate Clinical Professor, Movement Disorders Program
Associate Program Director, Neurology Residency
UCLA Department of Neurology*


* David Geffen School of Medicine at UCLA

Wesley T. Kerr, MD, PhD
Clinical Instructor
Department of Neurology
University of Michigan
Ann Arbor, MI

Peter A. Quiros, MD
Director, Foundations of Practice
Professor of Opthalmology
Department of Ophthalmology*

Lekha M. Rao, MD
Assistant Professor of Pediatric Neurology
UCLA Mattel Children’s Hospital
UCLA Department of Pediatrics*

Neal Rao, MD
Associate Clinical Professor, Vascular Neurology Program
Director, Olive View Medical Center Stroke Program
UCLA Department of Neurology*

Paola Sandroni, MD, PhD
Professor of Neurology, Mayo Clinic College of Medicine and Science
Chair, Division Autonomic Disorders Mayo Clinic Rochester, MN
Chair, Department of Neurology, Mayo Clinic
Mankato, Minnesota

Perry Shieh, MD, PhD
Professor of Neurology
UCLA Departments of Neurology
and Pediatrics*

Elyse J. Singer, MD
Professor of Neurology
UCLA Department of Neurology*

Paul M. Vespa, MD
Assistant Dean of Critical Care Medicine, Research
Gary L. Brinderson Family Chair in Neurocritical Care
Professor of Neurosurgery and Neurology
Director of the Neurocritical Care Program*

Pablo Villablanca, MD
Professor of Radiological Sciences
Chief of Diagnostic Neuroradiology
UCLA Department of Radiology*

Keith Vossel, MD, PhD
Center Director, Mary S. Easton Center for Alzheimer’s Disease Research
Professor of Neurology
UCLA Department of Neurology*

Neil Wenger, MD
Professor of Medicine
Director, UCLA Health Ethics Center
UCLA Department of Medicine*

DAY 1 (Friday, 3/24/2023)

7:45 am

Introduction and Welcome Address
Alon Y. Avidan, MD, MPH, Course Director
Kevin Patel, MD, Course Co-Director

8:00 am Synopsis of Pediatric Neurology: What Adult Neurologists Should Know
Lekha Rao, MD
9:00 am Practical Neurogenetic Cases
Brent Fogel, MD, PhD
10:00 am Workup and Management of New Onset Seizures
Jonathan C. Edwards, MD
11:00 am Workup and Management of Strokes
Neal Rao, MD
12:00 pm Intermission & Product Theater  
1:00 pm Neuroinfectious Disease Review
Elyse Singer, MD
2:00 pm Neurologic Manifestations of COVID-19 Infections
Ayush Batra, MD
3:00 pm Neuroimaging Signs that Neurologists Must Never Miss
Pablo Villablanca, MD
4:00 pm Neck & Back Pain: The Red Flags
Langston Holly, MD

DAY 2 (Saturday, 3/25/2023)

8:00 am What Neurologists Need to Know About Sleep
Alon Avidan, MD, MPH
9:00 am Everything that Shakes is not a Seizure: Video Demonstration
Wellesley Kerr, MD, PhD
10:00 am Practical Approaches to the Dizzy Patient
Gail Ishiyama, MD, PhD
11:00 am Movement Disorders Cases
Adrienne Keener, MD
12:00 pam Intermission & Product Theater  
1:00 pm Neuromuscular Disease cases
Perry Shieh, MD, PhD
2:00 ap  Dementia Cases
Keith Vossel, MD, PhD
3:30 pm Current & Emerging Treatments for Alzheimer’s Disease
Anna Burke, MD
4:30 pm Communicating Risk of Dementia: When, How, Why, and What
Neil Wenger, MD

DAY 3 (Sunday, 3/26/2023)

8:00 am Advances in Neurologic Critical Care
Paul M. Vespa, MD
9:00 am Vasculitis of the Central Nervous System
Shamik Bhattacharya, MD
10:00 am Nuero-Ophthalmology Pearls
Peter Quiros, MD
11:00 am An Update on the Management of Headache Disorders
Andrew Charles, MD
12:00 pm Intermission & Product Theater  
1:00 pm Practical Updates and Innovations in Neuro-Oncology
Robert Chong, MD, PhD
2:00 pm Autonomic Disorders
Paola Sandroni MD, PhD
3:00 pm A New Chapter in Multiple Sclerosis Diagnosis and Treatment
Kevin Patel, MD
4:00 pm Living Well with Multiple Sclerosis: A Comprehensive Approach
Barbara Giesser, MD
5:00 pm Conclusion and Adjournment
Alon Y. Avidan, MD, MPH, Course Director
Kevin Patel, MD, Course Co-Director

At the conclusion of this course, participants should be able to:

  • Utilize most current evidenced-based practices to improve confidence in diagnosing and managing major disease states in neurology, including multiple sclerosis, headaches, epilepsy, central nervous system infections including COVID-19 infection, movement disorders, neurodegenerative disorders, sleep disorders, neuromuscular diseases, neuro-otology, stroke management, neuro-ophthalmology, ethical principles of disclosure of neurodegenerative conditions in neurology.
  • Discuss neurologic disease utilizing a case-based approach across the age groups from pediatrics to an older age.
  • Explore the utility of neurologic testing, including cerebrospinal fluid analysis, neuropsychiatric testing, neuroimaging, and neurophysiological assessments, including polysomnography, electroencephalography, electromyography, and nerve conduction velocity testing.
  • Discuss the underlying neuropathology of key neurological conditions and appraise the utility of disease-modifying treatments in representative conditions, including Alzheimer’s disease and multiple sclerosis.
  • Identify appropriate the most current appropriate and innovative therapeutic strategies for common neurologic disorders and complaints.
  • Apply the principles of ethics to the disclosure of conditions and testing that might predict the risk of future development of neurodegenerative conditions.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 24.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed the 9th Annual UCLA Review of Clinical Neurology and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.


The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.